PLTR
Review & Preview: All Good Now
REVIEW PREVIEW NEWSLETTER A Software Revival. For long stretches of the last decade, tech stocks drove much of the market’s gains. The AI boom supercharged that trend, until it didn’t. Early in 2026, in fact, tech was the market’s kryptonite, with once-hot software companies largely to blame for the trouble.
Barrons.com  ·  May 01, 2026 READ →
ORCL
Review & Preview: All Good Now
REVIEW PREVIEW NEWSLETTER A Software Revival. For long stretches of the last decade, tech stocks drove much of the market’s gains. The AI boom supercharged that trend, until it didn’t. Early in 2026, in fact, tech was the market’s kryptonite, with once-hot software companies largely to blame for the trouble.
Barrons.com  ·  May 01, 2026 READ →
MSFT
Review & Preview: All Good Now
REVIEW PREVIEW NEWSLETTER A Software Revival. For long stretches of the last decade, tech stocks drove much of the market’s gains. The AI boom supercharged that trend, until it didn’t. Early in 2026, in fact, tech was the market’s kryptonite, with once-hot software companies largely to blame for the trouble.
Barrons.com  ·  May 01, 2026 READ →
CRM
Review & Preview: All Good Now
REVIEW PREVIEW NEWSLETTER A Software Revival. For long stretches of the last decade, tech stocks drove much of the market’s gains. The AI boom supercharged that trend, until it didn’t. Early in 2026, in fact, tech was the market’s kryptonite, with once-hot software companies largely to blame for the trouble.
Barrons.com  ·  May 01, 2026 READ →
INTC
Trump Says US Made Over $30 Billion On Intel Stock In Just 90 Days: 'I Have Been Very Successful...'
On Wednesday, President Donald Trump touted the federal government's investment in Intel Corp. as one of America's most lucrative strategic bets. Trump Celebrates Massive Intel Windfall In a post on Truth Social, Trump said the government's equity position in Intel had generated enormous returns since his administration authorized the investment last summer. "I'm very proud of that Company in that I am responsible for making the United States of America over 30 Billion Dollars in the last 90 day
Benzinga  ·  May 01, 2026 READ →
ETHUSDT
Crypto Markets Today, May 1: Bitcoin Holds Above $78,000 as Tech Stocks Set New Highs
On May 1, 2026, Bitcoin, Ethereum, and Solana extended gains despite concern about inflation, oil prices, and geopolitical tensions.
Motley Fool  ·  May 01, 2026 READ →
SOLUSDT
Crypto Markets Today, May 1: Bitcoin Holds Above $78,000 as Tech Stocks Set New Highs
On May 1, 2026, Bitcoin, Ethereum, and Solana extended gains despite concern about inflation, oil prices, and geopolitical tensions.
Motley Fool  ·  May 01, 2026 READ →
BTCUSDT
Crypto Markets Today, May 1: Bitcoin Holds Above $78,000 as Tech Stocks Set New Highs
On May 1, 2026, Bitcoin, Ethereum, and Solana extended gains despite concern about inflation, oil prices, and geopolitical tensions.
Motley Fool  ·  May 01, 2026 READ →
NVDA
Data Center Demand Drove Vertiv's Earnings up 83%, but Is This AI Infrastructure Play Worth its Lofy Valuation?
The industrial equipment supplier's growing backlog points to a strong multiyear growth runway ahead.
Motley Fool  ·  May 01, 2026 READ →
INTC
Data Center Demand Drove Vertiv's Earnings up 83%, but Is This AI Infrastructure Play Worth its Lofy Valuation?
The industrial equipment supplier's growing backlog points to a strong multiyear growth runway ahead.
Motley Fool  ·  May 01, 2026 READ →
LMT
Trump slashes U.S. presence in Germany by 5,000 amid Iran war friction
Investing.com -- U.S. military presence in Europe faced a sharp reduction on Friday after President Trump ordered the withdrawal of 5,000 troops from Germany, citing a widening rift with Berlin over the ongoing war in Iran.
Investing.com  ·  May 01, 2026 READ →
AMGN
Assessing Amgen (AMGN) Valuation After Recent Share Price Weakness And Pipeline Expectations
How Amgen’s Recent Share Performance Frames the Story Amgen (AMGN) has drawn attention after recent share price weakness, with a 1 day return of about a 5% decline and a past month move near a 7% decline, prompting investors to reassess the large biotech’s current positioning. See our latest analysis for Amgen. Set against a 1 year total shareholder return of 20.96% and a 5 year total shareholder return of 51.79%, the recent 1 month share price return of a 6.64% decline suggests momentum has...
Simply Wall St.  ·  May 01, 2026 READ →